Refractory thrombotic thrombocytopenic purpura treated with cyclosporine.
Bachman
W R
WR
Brennan
J K
JK
D000328:Adult; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D003613:Danazol / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007378:Interleukins / Q000502:physiology; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D010951:Plasma Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D013156:Splenectomy; D014750:Vincristine / Q000627:therapeutic use
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D007378:Interleukins; D008776:Methylprednisolone Hemisuccinate; D014750:Vincristine; D016572:Cyclosporine; D003613:Danazol